Finasteride was a known treatment for benign prostatic hyperplasia and Merck were granted a patent for this therapeutic application in 1978. Subsequently, Merck filed an application for the treatment of androgenic alopecia with a family of compounds including...
An important consideration in the development of a pharmaceutical or other biologically active product is gaining approval from regulators to market the product. The timescales involved in gaining approval can be daunting, particularly when they are compared with the...
Recent Comments